Pharmaceutical Compositions

Abstract: ABSTRACT The present invention relates to solid oral fixed dose compositions of metformin, atorvastatin, and valsartan, or their pharmaceutically acceptable salts, processes for the preparation thereof, and the use of the composition to treat certain diseases.

Patent Information

Application #

Filing Date

18 December 2023

Publication Number

40/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate Center, Indianapolis, Indiana 46285, United States of America

Inventors

1. ALLGEIER, Matthew Carl

c/o Eli Lilly and Company Indianapolis Indiana 46206-6288 United States of America P.O. Box 6288

2. ZHANG, Tony Yantao

c/o Eli Lilly and Company Indianapolis Indiana 46206-6288 United States of America P.O. Box 6288

Specification

Description:AS FILED PDF DOCUMENTS , Claims:AS FILED PDF DOCUMENTS

Documents

Application Documents

#	Name	Date
1	202318086364-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [18-12-2023(online)].pdf	2023-12-18
2	202318086364-STATEMENT OF UNDERTAKING (FORM 3) [18-12-2023(online)].pdf	2023-12-18
3	202318086364-REQUEST FOR EXAMINATION (FORM-18) [18-12-2023(online)].pdf	2023-12-18
4	202318086364-PROOF OF RIGHT [18-12-2023(online)].pdf	2023-12-18
5	202318086364-POWER OF AUTHORITY [18-12-2023(online)].pdf	2023-12-18
6	202318086364-FORM 18 [18-12-2023(online)].pdf	2023-12-18
7	202318086364-FORM 1 [18-12-2023(online)].pdf	2023-12-18
8	202318086364-FIGURE OF ABSTRACT [18-12-2023(online)].pdf	2023-12-18
9	202318086364-DECLARATION OF INVENTORSHIP (FORM 5) [18-12-2023(online)].pdf	2023-12-18
10	202318086364-COMPLETE SPECIFICATION [18-12-2023(online)].pdf	2023-12-18
11	202318086364-FORM 3 [08-05-2024(online)].pdf	2024-05-08